Transcriptomic and lipidomic analysis for corn adaptation to future climate
Advanced transcriptomic and lipidomic analyses reveal molecular adaptations in ERA corn hybrids under future climate conditions, aiding breeding programs for stress resilience and yield stability.
Overview
This solution employs cutting-edge transcriptomic and lipidomic analyses to understand how ERA corn hybrids adapt to future climate conditions characterized by increased temperatures and elevated CO₂ levels. By identifying gene expression changes and lipid modulation, this research aims to uncover key regulatory pathways and stress response mechanisms that enable corn to maintain resilience and yield stability. These insights are crucial for breeding programs focused on enhancing adaptive traits, ultimately supporting the development of corn hybrids that can withstand anticipated climate challenges.
Technical specifications
Key features:
- Transcriptomic analysis: Identifies differentially expressed genes (DEGs) that facilitate stress adaptation.
- Lipidomic analysis: Examines lipid composition changes, focusing on stress-responsive lipids crucial for cell integrity.
- Simulation of future climate conditions: Utilizes Biotran Facility to replicate IPCC-projected climate scenarios (2-3°C increase, 600 ppm CO₂).
- Advanced bioinformatics tools: Integrate transcriptomic and lipidomic data to identify regulatory networks and analyze gene-lipid interactions.
Technology readiness level
This research is currently at Technology Readiness Level 3, indicating experimental proof of concept. The study will be conducted using simulation facilities to evaluate the performance of ERA corn hybrids under controlled future climate conditions.
About Western University
Western University is a comprehensive public research university in London, Ontario, with a full spectrum of professional and research programs and a strong culture of partnership with industry. Companies engage through co-located labs and shared core facilities, a research and technology park with industry tenancy, and advanced prototyping testbeds that enable scale-up. Integration with major hospital systems and affiliated research institutes supports clinical translation and trials, while co-op and internship pathways provide reliable talent pipelines. Research is backed by competitive funding from NSERC, CIHR, SSHRC, and the Canada Foundation for Innovation, and a dedicated technology transfer office offers IP strategy, licensing, and startup support.
delivered to your inbox.